Screening experience and baseline characteristics in the West of Scotland coronary prevention study

The American Journal of Cardiology

Volumn 76, Issue 7, 1995, Pages 485-491

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

PRAVASTATIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DOUBLE BLIND PROCEDURE; GEOGRAPHIC DISTRIBUTION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNITED KINGDOM;

AGE FACTORS; CHOLESTEROL; CORONARY DISEASE; DOUBLE-BLIND METHOD; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT SELECTION; PRAVASTATIN; REFERENCE VALUES; RISK FACTORS; SCOTLAND; TRIGLYCERIDES;

EID: 0029077174     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)80135-0     Document Type: Article

References (21)

1. Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors
2. Pravastatin experience in elderly and non-elderly patients
3. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
4. W.H.O. Clofibrate Trial: cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up report
5. The coronary primary prevention trial: Design and implementation
6. The Lipid Research Clinics Coronary Primary Prevention Trial Results
7. The Helsinki Heart Study: Basic design and randomization procedure
8. The Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease
9. A coronary primary prevention study of Scottish men aged 45?64 years: Trial design
10. Automated serial ECG comparison using the Minnesota code (abstr)
11. Concomitants of excess coronary deaths—major risk factor and lifestyle findings from 10, 359 men and women in the Scottish Heart Health Study
12. Report of the conference on low blood cholesterol: mortality associations
13. Are low cholesterol values associated with excess mortality?
14. Serum cholesterol levels and cancer mortality in 361, 662 men screened for the Multiple Risk Factor Intervention Trial
15. The serum cholesterol-cancer relationship: an analysis of time trends in the Framingham Study
16. Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey
17. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials
18. Editorial. Health policy on blood cholesterol: time to change directions
19. Assessing possible hazards of reducing serum cholesterol
20. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)